The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027. These devices are used in ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Daniel Davis to its Board of Directors.

The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for ...

A new study published in The New England Journal of Medicine showed that stroke was not prevented by routinely using devices ...

The number one cause of death in Korea is still malignant neoplasms (cancer), followed by cerebrovascular disease and heart ...

The Germany Cardiovascular Devices Market is projected to grow by US$ 1.68 billion during the forecast period of 2020-2026, at a robust CAGR of 6.9%. Get a Free Sample PDF copy of the report @- https: ...

Breast cancer can be treated WITHOUT surgery? New study spills the beans on stroke-prevention pacemaker that works on ...

Kevin Campbell’s feats earned him legendary status at a host of clubs he represented, including Everton - Getty Images/Clive Brunskill ...

StockNews.com assumed coverage on shares of InspireMD (NYSE:NSPR – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock. Separately, Lake ...

Cervical artery dissection is a tear in an artery in the neck that provides blood flow to the brain. Such a tear can result in blood clots that cause stroke. A new study has found almost a five-fold ...

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.